Detalhe da pesquisa
1.
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer.
Ann Oncol
; 29(9): 1918-1925, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016392
2.
Climbazole increases expression of cornified envelope proteins in primary keratinocytes.
Int J Cosmet Sci
; 36(5): 419-26, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24811958
3.
Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours.
Br J Cancer
; 104(7): 1067-70, 2011 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-21386841
4.
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer.
Br J Cancer
; 104(12): 1822-7, 2011 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21587257
5.
Self-rated health in individuals with and without disease is associated with multiple biomarkers representing multiple biological domains.
Sci Rep
; 11(1): 6139, 2021 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731775
6.
Some observations on the reversibility of methotrexate toxicity in normal proliferating tissues.
J Natl Cancer Inst
; 58(1): 91-7, 1977 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-299894
7.
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee.
J Natl Cancer Inst
; 85(22): 1812-8, 1993 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-8230261
8.
Thymidine phosphorylase moderates thymidine-dependent rescue after exposure to the thymidylate synthase inhibitor ZD1694 (Tomudex) in vitro.
Cancer Res
; 58(13): 2737-40, 1998 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9661884
9.
Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule.
J Clin Oncol
; 11(11): 2112-7, 1993 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-8229125
10.
Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancer.
J Clin Oncol
; 9(12): 2141-7, 1991 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-1960556
11.
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin.
J Clin Oncol
; 19(5): 1336-43, 2001 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11230476
12.
Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000.
J Clin Oncol
; 21(2): 203-10, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12525511
13.
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C.
J Clin Oncol
; 19(5): 1485-92, 2001 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11230495
14.
Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects.
Clin Cancer Res
; 5(7): 1682-9, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10430069
15.
Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.
Clin Cancer Res
; 5(3): 513-20, 1999 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10100701
16.
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
Clin Cancer Res
; 6(12): 4697-704, 2000 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-11156222
17.
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.
Clin Cancer Res
; 7(7): 1912-22, 2001 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-11448904
18.
A novel cyclic adenosine monophosphate analog induces hypercalcemia via production of 1,25-dihydroxyvitamin D in patients with solid tumors.
J Clin Endocrinol Metab
; 82(12): 4044-8, 1997 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-9398710
19.
Phase II study of liarozole in advanced non-small cell lung cancer.
Eur J Cancer
; 34(9): 1463-6, 1998 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-9849433
20.
Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancer.
Lung Cancer
; 41(2): 215-9, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12871785